Pfizer Biontech
World  /  Published 27.08.22

Moderna suing Pfizer

A strike by Scottish refuse workers over pay is spreading to more cities, with garbage from unattended bins overflowing onto Edinburgh’shigh streets, raising a stink during the city’s inte...
By Reuters in New York

World  /  Published 20.06.22

Parents face jab dilemma

It’s a moment many parents have anxiously awaited for months: Children younger than five years are now eligible for vaccination against the coronavirus, among the last Americans to qualify. Wit...
By Apoorva Mandavilli

India  /  Published 27.01.22

Omicron booster for better immunity: Study

Research by Indian scientists has suggested that people infected with omicron after full immunisation with the AstraZeneca or Pfizer-BioNTech Covid-19 vaccines have significant immune responses that p...
By GS Mudur in New Delhi

World  /  Published 22.01.22

Boosters key to Covid fight

Booster shots of the Pfizer-BioNTech and Moderna vaccines aren’t just preventing infections with the contagious Omicron variant —  they’re also keeping infected Americans from e...
By Apoorva Mandavilli in New York

World  /  Published 22.10.21

Pfizer booster jab

Pfizer Inc and German partner BioNTech SE on Thursday said data from a Phase III trial demonstrated high efficacy of a booster dose of their Covid-19 vaccine against the virus, including the Delta var...
By Reuters in Berlin


India  /  Published 21.09.21

India won't buy Pfizer, Moderna jabs: Report

India's government will not buy COVID-19 shots from Pfizer/BioNTech and Moderna, three government sources told Reuters, mainly because domestic output of more affordable and easier-to-store vaccin...
By Reuters in New Delhi

India  /  Published 20.09.21

Pfizer-BioNTech vaccine safe for kids of 5-11 yrs

Global pharma major Pfizer and BioNTech SE on Monday said trial results of COVID-19 vaccine showed that it is safe and produced robust neutralizing antibody response in children aged five to 11 years,...
By Our bureau and PTI in New Delhi

World  /  Published 18.08.21

Jab effective against Delta variant

The Delta variant of the SARS-CoV-2 virus, that causes Covid-19, is unable to evade the antibodies generated by vaccination, according to a lab study. The findings, published in the journal Immunity,...
By Our Bureau, PTI in Washington

World  /  Published 24.07.21

Pfizer: longer gap boosts immunity

A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found. The study, led by the University ...
By H S Rao in London

World  /  Published 14.07.21

More Pfizer booster-shot data needed

Representatives of Pfizer met privately with senior US scientists and regulators on Monday to press their case for swift authorisation of coronavirus booster vaccines, amid growing public confusion ab...
By Sheryl Gay Stolberg, Sharon LaFraniere in Washington


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.